PNR vs TRVI · P/E 18, rev $4.18B vs $2.32B cap
Pentair PLC (PNR) versus Trevi Therapeutics Inc (TRVI) — a side-by-side from cached financials, not a winner call.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Latest reported PNR revenue for 2025-12-31 was $4.18B. Net income was $653.8M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
TRVI does not have a complete income-statement cache yet.
PNR currently screens at market cap $11.86B and trailing P/E 18.4. TRVI currently screens at market cap $2.32B.
Not investment advice. Open the PNR and TRVI stock pages for the full models.
Not investment advice.